Balaji Pharmaceutical Ltd

POWER SEARCH PRICING

SOLUTIONS

balaji pharmaceutical ltd Company Information

Live

EstablishedSmallHigh

Company Number

06863514

Website

Registered Address

3 the oval, sidcup, kent, DA15 9ER

Industry

Dispensing chemist in specialised stores

Telephone

02083021862

Next Accounts Due

December 2024

Group Structure

View All

Directors

Sajal Patel15 Years

Dipesh Patel1 Years

Shareholders

sajal patel 50%

dipesh praful patel 50%

balaji pharmaceutical ltd Estimated Valuation

£326k

Pomanda estimates the enterprise value of BALAJI PHARMACEUTICAL LTD at £326k based on a Turnover of £1.2m and 0.28x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Balaji Pharmaceutical Ltd is a live company located in kent, DA15 9ER with a Companies House number of 06863514. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 2009, it's largest shareholder is sajal patel with a 50% stake. Balaji Pharmaceutical Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.2m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Balaji Pharmaceutical Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating2out of 5

2 Strong

3 Regular

7 Weak

Size

annual sales of £1.2m, make it smaller than the average company (£11.5m)

Growth

3 year (CAGR) sales growth of 19%, show it is growing at a faster rate (5.3%)

EXPORT

Balaji Pharmaceutical Ltd's latest turnover from March 2023 is estimated at £1.2 million and the company has net assets of £101.6 thousand. According to their latest financial statements, Balaji Pharmaceutical Ltd has 14 employees and maintains cash reserves of £2.5 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Turnover	1,173,953	869,724	822,801	700,282	536,151	657,842	722,915	673,915	834,495	803,014	806,022	1,011,471
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	853,252	630,715	619,783	527,813	402,294	483,243	524,719	491,697	612,897	579,333	585,592	746,750
Gross Profit	320,702	239,009	203,018	172,469	133,857	174,599	198,196	182,218	221,597	223,681	220,430	264,721
Admin Expenses	387,460	176,201	138,342	187,969	159,203	145,316	160,109	169,703	211,424	209,703	212,800	231,102
Operating Profit	-66,758	62,808	64,676	-15,500	-25,346	29,283	38,087	12,515	10,173	13,978	7,630	33,619
Interest Payable	0	0	0	1,063	2,478	2,654	2,538	1,239	0	0	0	0
Interest Receivable	720	209	13	2	7	7	6	11	14	33	32	11
Pre-Tax Profit	-66,038	63,016	64,689	-16,561	-27,817	26,636	35,555	11,288	10,187	14,010	7,662	33,630
Tax	0	-11,973	-12,291	0	0	-5,061	-7,111	-2,257	-2,139	-3,222	-1,839	-8,744
Profit After Tax	-66,038	51,043	52,398	-16,561	-27,817	21,575	28,444	9,030	8,048	10,788	5,823	24,886
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-66,038	51,043	52,398	-16,561	-27,817	21,575	28,444	9,030	8,048	10,788	5,823	24,886
Employee Costs	307,393	205,562	193,777	170,351	166,466	182,512	177,058	86,966	103,581	103,371	101,395	117,776
Number Of Employees	14	10	10	9	9	10	10	5	6	6	6	7
EBITDA*	-47,927	80,802	82,786	2,326	-7,245	47,631	56,690	12,515	29,811	34,496	12,321	33,619

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Tangible Assets	409,743	407,236	407,577	406,726	3,301	4,045	4,810	5,937	7,916	10,554	14,072	0
Intangible Assets	0	17,001	34,000	51,000	68,000	84,999	101,999	118,999	135,999	152,999	169,999	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	409,743	424,237	441,577	457,726	71,301	89,044	106,809	124,936	143,915	163,553	184,071	0
Stock & work in progress	42,750	33,332	41,257	53,471	57,380	62,383	72,750	79,950	77,500	75,000	72,500	62,000
Trade Debtors	200,083	196,098	198,175	151,297	75,732	116,101	137,938	136,665	162,054	155,941	166,489	233,727
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	0	0	65,083	39,209	29,935	13,060	0	0	0	11,451
Cash	2,467	31,409	24,196	2,496	885	911	1,761	3,354	1,068	4,524	8,580	4,302
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	245,300	260,839	263,628	207,264	199,080	218,604	242,384	233,029	240,622	235,465	247,569	311,480
total assets	655,043	685,076	705,205	664,990	270,381	307,648	349,193	357,965	384,537	399,018	431,640	311,480
Bank overdraft	0	0	0	0	13,931	13,021	13,239	4,080	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	149,707	104,121	134,189	121,469	84,613	122,198	135,738	162,178	230,111	219,431	215,993	286,592
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	0	0	20,618	37,511	82,367	56,589	0	0	0	0
total current liabilities	149,707	104,121	134,189	121,469	119,162	172,730	231,344	222,847	230,111	219,431	215,993	286,592
loans	0	0	0	0	20,913	25,549	29,862	34,033	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	403,711	413,292	453,764	478,829	48,896	0	0	42,504	104,879	138,088	184,936	0
provisions	0	0	632	470	627	769	962	0	0	0	0	0
total long term liabilities	403,711	413,292	454,396	479,299	70,436	26,318	30,824	76,537	104,879	138,088	184,936	0
total liabilities	553,418	517,413	588,585	600,768	189,598	199,048	262,168	299,384	334,990	357,519	400,929	286,592
net assets	101,625	167,663	116,620	64,222	80,783	108,600	87,025	58,581	49,547	41,499	30,711	24,888
total shareholders funds	101,625	167,663	116,620	64,222	80,783	108,600	87,025	58,581	49,547	41,499	30,711	24,888

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-66,758	62,808	64,676	-15,500	-25,346	29,283	38,087	12,515	10,173	13,978	7,630	33,619	0	0
Depreciation	1,830	995	1,110	826	1,101	1,348	1,603	0	2,638	3,518	4,691	0	0	0
Amortisation	17,001	16,999	17,000	17,000	17,000	17,000	17,000	0	17,000	17,000	0	0	0	0
Tax	0	-11,973	-12,291	0	0	-5,061	-7,111	-2,257	-2,139	-3,222	-1,839	-8,744	0	0
Stock	9,418	-7,925	-12,214	-3,909	-5,003	-10,367	-7,200	2,450	2,500	2,500	10,500	62,000	0	0
Debtors	3,985	-2,077	46,878	10,482	-14,495	-12,563	18,148	-12,329	6,113	-10,548	-78,689	245,178	0	0
Creditors	45,586	-30,068	12,720	36,856	-37,585	-13,540	-26,440	-67,933	10,680	3,438	-70,599	286,592	0	0
Accruals and Deferred Income	0	0	0	-20,618	-16,893	-44,856	25,778	56,589	0	0	0	0	0	0
Deferred Taxes & Provisions	0	-632	162	-157	-142	-193	962	0	0	0	0	0	0	0
Cash flow from operations	-15,744	48,131	48,713	11,834	-42,367	6,911	38,931	8,793	29,739	42,760	8,072	4,289	0	0
Investing Activities
capital expenditure	-4,337	-654	-1,961	-404,251	-358	-583	-476	18,979	0	0	-188,762	0	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-4,337	-654	-1,961	-404,251	-358	-583	-476	18,979	0	0	-188,762	0	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	-20,913	-4,636	-4,313	-4,171	34,033	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	-9,581	-40,472	-25,065	429,933	48,896	0	-42,504	-62,375	-33,209	-46,848	184,936	0	0	0
share issue	0	0	0	0	0	0	0	4	0	0	0	2	0	0
interest	720	209	13	-1,061	-2,471	-2,647	-2,532	-1,228	14	33	32	11	0	0
cash flow from financing	-8,861	-40,263	-25,052	407,959	41,789	-6,960	-49,207	-29,566	-33,195	-46,815	184,968	13	0	0
cash and cash equivalents
cash	-28,942	7,213	21,700	1,611	-26	-850	-1,593	2,286	-3,456	-4,056	4,278	4,302	0	0
overdraft	0	0	0	-13,931	910	-218	9,159	4,080	0	0	0	0	0	0
change in cash	-28,942	7,213	21,700	15,542	-936	-632	-10,752	-1,794	-3,456	-4,056	4,278	4,302	0	0

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for balaji pharmaceutical ltd. Get real-time insights into balaji pharmaceutical ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for balaji pharmaceutical ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in DA15 area or any other competitors across 12 key performance metrics.

BALAJI PHARMACEUTICAL LTD group structure

Balaji Pharmaceutical Ltd has no subsidiary companies.

Ultimate parent company

BALAJI PHARMACEUTICAL LTD

06863514

BALAJI PHARMACEUTICAL LTD Shareholders

sajal patel	50%
dipesh praful patel	50%

Balaji Pharmaceutical Ltd currently has 2 directors. The longest serving directors include Mrs Sajal Patel (Mar 2009) and Mr Dipesh Patel (Feb 2023).

officer	country	age	start	end	role
Mrs Sajal Patel	England	49 years	Mar 2009	-	Director
Mr Dipesh Patel	England	51 years	Feb 2023	-	Director

P&L

March 2023

turnover

1.2m

+35%

operating profit

-66.8k

gross margin

27.4%

-0.59%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

101.6k

-0.39%

total assets

655k

-0.04%

cash

2.5k

-0.92%

net assets

Total assets minus all liabilities

Similar Companies

iceline trading limited

brookpharm limited

lords pharmacy limited

4.5

friends pharmacy limited

perimart limited

company number

06863514

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

March 2009

ultimate parent company

None

previous names

N/A

address

3 the oval, sidcup, kent, DA15 9ER

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to balaji pharmaceutical ltd. Currently there are 3 open charges and 0 have been satisfied in the past.

balaji pharmaceutical ltd Company Information

balaji pharmaceutical ltd Estimated Valuation

balaji pharmaceutical ltd Estimated Valuation

balaji pharmaceutical ltd Estimated Valuation

Balaji Pharmaceutical Ltd Overview

Balaji Pharmaceutical Ltd Health Check

BALAJI PHARMACEUTICAL LTD financials

balaji pharmaceutical ltd Credit Report and Business Information

Balaji Pharmaceutical Ltd Competitor Analysis

balaji pharmaceutical ltd Ownership

balaji pharmaceutical ltd directors

balaji pharmaceutical ltd company details

balaji pharmaceutical ltd Charges & Mortgages

balaji pharmaceutical ltd Companies House Filings - See Documents